Uric acid - its role as a risk factor for the metabolic syndrome, cardiovascular and kidney disease
Thesis introduction (PDF)
Paper I: Norvik, J. V., Storhaug, H. M., Ytrehus, K., Jenssen, T., Zykova, S., Eriksen, B. O., Solbu, M. D.: “Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study”. Also available in BMC Cardiovascular Disorders 2016, 16:85. (PDF)
Paper II: Storhaug, H. M., Toft, I., Norvik, J. V., Jenssen, T., Eriksen, B. O., Melsom, T., Løchen, M. L., Solbu, M. D.: «Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study”. Also available in BMC Nephrology 2015, 16:210. (PDF)
Paper III: Storhaug, H. M., Norvik, J. V., Toft, I., Eriksen, B. O., Løchen, M. L., Zykova, S., Solbu, M. D., White, S., Chadban, S., Jenssen, T.: “Uric acid is a risk factor for ischemic stroke and allcause mortality in the general population: a gender specific analysis from The Tromsø Study”. Also available in BMC Cardiovascular Disorders 2013, 13:115. (PDF)
Uric acid as a potential risk factor for cardiovascular and renal conditions has gained renewed attention. In this work we aimed to assess the associations between serum uric acid, metabolic syndrome, hypertension, renal dysfunction, cardiovascular events and mortality. In paper I, 6083 participants from Tromsø 4 were stratified according to body mass index. Endpoints were the metabolic syndrome and each component of the syndrome after seven years. Increased levels of baseline serum uric acid independently predicted development of hypertension and higher fasting glycemia in the overweight, but not in the normal-weight subjects. Baseline and longitudinal serum uric acid were both predictors of future metabolic syndrome. A prospective study that included 2637 participants who participated in Tromsø 4, 5 and 6 was described in paper II. We assessed the associations between change in serum uric acid during follow-up, baseline serum uric acid and renal dysfunction (defined as albumin-creatinine-ratio ≥1.13 mg albumin/mmol creatinine and/or estimated glomerular filtration rate < 60 ml/min/1.73 m2). Participants were stratified according to tertiles of change in serum uric acid between baseline and follow-up 13 years later. The upper tertile, compared to the two lower tertiles, had a doubled risk of renal dysfunction after 7 years, and after 13 years the odds ratio for renal dysfunction was 2.18. The risk of developing albumin-creatinine-ratio ≥1.13 mg/mmol alone was also significantly increased. An increase in baseline serum uric acid of 59 μmol/L gave an odds ratio of 1.16 for renal dysfunction after 13 years. In paper III, we included 5700 participants from Tromsø 4, and assessed the associations between serum uric acid and all-cause mortality after 15 years, and fatal or non-fatal myocardial infarction and ischemic stroke after 12 years. Serum uric acid was associated with all-cause mortality in men and women, even after adjustment for blood pressure, estimated glomerular filtration rate, urinary albumin creatinine-ratio, drug intake and traditional cardiovascular risk factors. After the same adjustments, serum uric acid was associated with a 31% increased risk of stroke in men. No independent association between increment in serum uric acid and myocardial infarction was observed. Our findings support the view that serum uric acid is associated with obesity, metabolic syndrome and hypertension, but also is a risk factor for cardiovascular and kidney disease, independently of these risk factors. Moreover, increasing values of serum uric acid over time may imply an even higher risk.
PublisherUiT The Arctic University of Norway
UiT Norges arktiske universitet
The following license file are associated with this item:
Showing items related by title, author, creator and subject.
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma : VEGF-A Impact Is Strongly Associated with Ang-2 Andersen, Sigve; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and ...
Humant papillomavirus : en litteraturstudie om HPV, dets relasjon til cancer og tiltak mot videre spredning av virus Gabrielsen, Endre (Master thesis; Mastergradsoppgave, 2012-06-01)I 1983 oppdaget zur Hausen sammenhengen mellom Humant Papillomavirus (HPV) og livmorhalskreft. På denne tiden visste man ikke at det var HPV som var årsaken til at Helaceller kunne leve in vitro. Ny forskning relaterer HPV til en rekke andre cancertyper. En stor andel anal-, oropharyngeal-, penis-, vaginal-, og vulvacancer skyldes HPV. Det er også påvist HPV i tumorvev fra øsofagus, larynx, lunge, ...
Cardiovascular adaptation in pregnancy - Effects of angiotensin II, transverse aorta constriction and high-intensity interval training on pregnant rats Songstad, Nils Thomas (Doctoral thesis; Doktorgradsavhandling, 2014-09-18)Objectives: To investigate how cardiac function, remodeling and gene expression are affected in pregnancy in response to cardiovascular stress, to detect possible adverse effects on the fetus, and to evaluate if coronary endothelial function is influenced by pregnancy and increased cardiac afterload. Methods: Pregnant and non-pregnant rats were subjected to chronic AngII-infusion, transverse aortic ...